Drug details
Belbuca (buprenorphine buccal film)
type of Analgesics, Opioid Partial Agonist
Belbuca (buprenorphine) buccal film contains a partial opioid agonist and is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- nausea,
- loss of appetite,
- rash,
- diarrhea,
- fever,
- pale skin,
- lightheadedness,
- confusion,
- chills,
- stomach pain,
- dizziness,
- blurred vision,
- back pain,
- headache,
- nervousness,
- pounding in the ears,
- cough,
- agitation,
- darkening of the skin,
- restlessness,
- vomiting
- chest pain or pressure,
- shallow breathing,
- drowsiness,
- irregular heartbeat,
- rapid weight gain,
- abdominal pain,
- depression,
- tremors,
- frequent urination,
- loss of coordination,
- swelling of the face, arms, hands, ankles or feet,
- blood in your urine,
- mouth pain,
- slow or fast heartbeats,
- tingling in the hands or feet,
- tiredness or weakness,
- unusual bruising or bleeding,
- breathing that stops in your sleep,
- swelling around the eyes, lips or tongue,
- extreme excitement,
- muscle spasms, and
The following drugs are related to Belbuca, either as a replacement or used together:
- Actiq (fentanyl citrate)
- Brixadi (buprenorphine extended-release injection)
- Stadol (butorphanol tartrate)
- Cymbalta (duloxetine hcl)
- Demerol (meperidine)
- Exalgo (hydromorphone hydrochloride extended release tablets)
- Zamicet (hydrocodone bitartrate and acetaminophen oral solution)
- Kadian (morphine sulfate extended-release)
- Opvee (nalmefene nasal spray)
- Oxaydo (oxycodone hcl usp tablets)
- Oxecta (oxycodone hcl, usp tablets)